Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

served as Chief Executive Officer of a Catalio Capital-backed oncology company, which he led from formation through a $14 million seed financing to a successful corporate transaction. He previously held Chief Operating Officer and Chief Technology...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with gene-to-antibody delivery in as little as 7 calendar days, plus 5 days for shipping, for...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with gene-to-antibody delivery in as little as 7 calendar days, plus 5 days for shipping, for...

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

their pain immediately before each dose and again in the hours after, participants' scores fell from 5.26 to 3.56 on a 0–10 scale — a 32% drop (p...

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the risk of clinical worsening...

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

the American National Standards Institute (ANSI) and the International Safety Equipment Association (ISEA), ANSI/ISEA Z308.1-2026. This new standard reflects a significant shift in how employers approach emergency preparedness, recognizing naloxone...

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

and lead investigator of the study. Key Findings Statistically Significant reduction in recurrent atrial arrhythmia events: 12 events with MNS compared with 28 with sham in the post-blanking sensitivity analysis (p = 0.025) 90.0% freedom from...

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

Bruker Corporation announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to...

Scitara Appoints Mike Tarselli as Chief Strategy Officer to Drive Growth in Lab Intelligence

Scitara, the Lab Connectivity and AI platform company serving the life sciences and biopharma industries, announced a new strategic direction for the company alongside the appointment of Mike Tarselli, Ph.D., MBA, as Chief Strategy Officer. The...

Stasis Introduces the First Day-and-Night Supplement System Built for Children Who Take Stimulants

stimulants, today introduced Stasis Kids, a day-and-night nutritional supplement system made for children ages 6 to 17. In 2023, 16.5 million people in the United States were dispensed a prescription stimulant, up 48 percent in a decade, according...

Chemify Becomes the First Chemistry Hyperscaler with £22 Million in Grants from Scottish Enterprise and the UK Government

chemistry to partners across pharmaceuticals, speciality chemicals and advanced materials. The grant package includes £16 million ($21.6 million) from Scottish Enterprise and £6 million ($8.1 million) from the UK Government. Chemify’s previously...

Lundbeck Receives Marketing Authorization for Vyepti® (eptinezumab) in Japan for the Prevention of Migraine Attacks

often accompanied by nausea, vomiting, and sensitivity to light and sound. In Japan, migraine affects an estimated 8.4%–11.0% of the population1 and is the fourth leading cause of years lived with disability.2 Beyond the physical symptoms, migraine...

Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish a Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery

to develop innovative solutions that help improve lives worldwide. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 dedicated people across 20 countries. For more information please visit, http://www.aptar.com.

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

of the existing portfolio while simplifying virus filtration processes. Its compact design accommodates workflows using 0.12 m² or 0.3 m² Planova™ 35N virus-removal filters. The VANTIJ® simplifies small-scale Planova™ virus filtration while...

PHC Launched MTR-OPC1-PW Interface Board in September to Strengthen Data Linkage Between Equipment and Customer Systems

referred to as "PHC") Life Science Division Biomedica Business Group (PHCbi) is pleased to announce that the MTR-OPC-OPC1-PW, an interface board compatible with the OPC UA ®(*2) standard, will be launched in September to strengthen data...

Avenacy Launched Cyclophosphamide for Injection, USP in the U.S. Market

are unable to tolerate adrenocorticosteroid therapy. Avenacy’s Cyclophosphamide for Injection, USP is available in 500 mg, 1 gram, and 2 gram single-dose vials, with one vial per carton. In line with Avenacy’s mission to champion patient safety and...

5th MENA Congress for Rare Diseases 2026

aspects related to rare diseases and including presentations, panel discussions, and workshops delivered by more than 150 speakers, including more than 50 international experts coming from more than 20 different countries. In addition, the congress...

New HCPCS Billing Code Enables Medicare Reimbursement for Lasix® ONYU When Furnished Incident to a Physician’s Service

Medicare & Medicaid Services (CMS) has established a new Healthcare Common Procedure Coding System (HCPCS) Level II code, J1946 ("Injection, furosemide (Lasix ONYU), 1 mg"), for its product Lasix® ONYU (furosemide injection). The code was published...

Jarrow Formulas® Launches Gut & Protein Optimizer and NMN 300 mg to Support Protein Absorption, Cellular Energy, and Healthy Aging

the protein conversation has largely focused on quantity: how many grams of protein consumers can add to their diets.1 Jarrow Formulas® Gut & Protein Optimizer takes a different approach by helping consumers get more from every gram they already...

Abbott Launched the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at a Price Similar to Its Existing Similac Powdered Formula

or exceed industry regulations for infant formula testing. About Similac® Similac has been feeding babies for more than 100 years. Backed by Abbott's science and research, Similac is committed to supporting parents with high-quality infant...